Ovarian cancer, version 2.2013 Journal Article


Authors: Morgan, R. J. Jr; Alvarez, R. D.; Armstrong, D. K.; Burger, R. A.; Chen, L. M.; Copeland, L.; Crispens, M. A.; Gershenson, D. M.; Gray, H. J.; Hakam, A.; Havrilesky, L. J.; Johnston, C.; Lele, S.; Martin, L.; Matulonis, U. A.; O'Malley, D. M.; Penson, R. T.; Powell, M. A.; Remmenga, S. W.; Sabbatini, P.; Santoso, J. T.; Schink, J. C.; Teng, N.; Werner, T. L.; Dwyer, M. A.; Hughes, M.
Article Title: Ovarian cancer, version 2.2013
Abstract: These NCCN Guidelines Insights focus on the major updates to the 2013 NCCN Guidelines for Ovarian Cancer. Four updates were selected based on recent important updates in the guidelines and on debate among panel members about recent clinical trials. The topics include 1) intraperitoneal chemotherapy, 2) CA-125 monitoring for ovarian cancer recurrence, 3) surveillance recommendations for less common ovarian histopathologies, and 4) recent changes in therapy for recurrent epithelial ovarian cancer. These NCCN Guidelines Insights also discuss why some recommendations were not made. © JNCCN-Journal of the National Comprehensive Cancer Network.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 11
Issue: 10
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2013-10-01
Start Page: 1199
End Page: 1209
Language: English
PROVIDER: scopus
PUBMED: 24142821
DOI/URL:
Notes: --- - "Export Date: 2 December 2013" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Paul J Sabbatini
    258 Sabbatini
Related MSK Work